2000 – FDA warns AbbVie that claims suggesting AndroGel is indicated for men with “age-associated hypogonadism” or “andropause” are misleading.
2000 – FDA issues warning
Announcement Date: March 1, 2000
2000 – FDA warns AbbVie that claims suggesting AndroGel is indicated for men with “age-associated hypogonadism” or “andropause” are misleading.